6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 12M49
Book a meeting

DIATHEVA

About DIATHEVA

Diatheva, part of SOL Group (30+ countries, 7,000+ employees), is an Italian biotech company offering CDMO services for third parties and specializing in two main strategic areas: -Biotechnological Products: flexible, end-to-end solutions for R&D and small-scale GMP production of APIs and sterile liquid finished forms (mAbs, antibody fragments, recombinant proteins, enzymes, antigens) for early clinical development, including formulation and aseptic filling. -Molecular & Immunoenzymatic Assays: design and manufacturing of IVD, veterinary, food safety, and environmental assays. Diatheva employs 20 people (70% PhDs) overseeing all stages from R&D to production.

Read more Show less
Certifications
  • CE
    CE
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 12M49
  • Country/Region:
    Italy
  • Founded:
    2002
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Generic APIs producer
Contact info
Show contact info Hide contact info

DIATHEVA Resources (3)

  • We are Diatheva

    Video We are Diatheva

    At Diatheva, biotechnology is more than innovation: it’s the people who drive it forward every day.
    2026-09-08
  • Brochure CDMO

    Brochure Brochure CDMO

    Reliable and customized solutions, boosting flexibility and speed in biotech CDMO, from R&D to production of APIs and sterile liquid finished forms.
  • Diagnostics and Biotech CDMO solutions

    Video Diagnostics and Biotech CDMO solutions

    Competence, flexibility, and reliability are the foundations of our daily work. As explained by our General Manager, Massimiliano Carreri, we operate through two dedicated Business Units:

    Diagnostics: research, development, and production of innovative kits for clinical, veterinary, environmental, and food applications.Biotech CDMO: tailored services for pharmaceutical companies, with a focus on clinical development.Our strength lies in speed and adaptability, ensuring that every client’s needs are met with precision. Looking ahead, we aim to expand our diagnostics portfolio, strengthen our international presence, and become a trusted reference in the biotech CDMO field.

    2026-09-08